| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Timothy Peters-Strickland, Cathy Zhao, Pamela P Perry, Anna Eramo, Phyllis M Salzman, Robert D McQuade, Brian R Johnson, Raymond Sanche. Effects of aripiprazole once-monthly on symptoms of schizophrenia in patients switched from oral antipsychotics. CNS spectrums. vol 21. issue 6. 2017-06-29. PMID:27531181. |
to assess the effects of aripiprazole once-monthly 400 mg (aom 400) on clinical symptoms and global improvement in schizophrenia after switching from an oral antipsychotic. |
2017-06-29 |
2023-08-13 |
Not clear |
| Henry A Nasrallah, John W Newcomer, Robert Risinger, Yangchun Du, Jacqueline Zummo, Anjana Bose, Srdjan Stankovic, Bernard L Silverman, Elliot W Ehric. Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia. The Journal of clinical psychiatry. vol 77. issue 11. 2017-05-25. PMID:27574838. |
effect of aripiprazole lauroxil on metabolic and endocrine profiles and related safety considerations among patients with acute schizophrenia. |
2017-05-25 |
2023-08-13 |
Not clear |
| Henry A Nasrallah, John W Newcomer, Robert Risinger, Yangchun Du, Jacqueline Zummo, Anjana Bose, Srdjan Stankovic, Bernard L Silverman, Elliot W Ehric. Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia. The Journal of clinical psychiatry. vol 77. issue 11. 2017-05-25. PMID:27574838. |
aripiprazole lauroxil, a long-acting injectable antipsychotic, demonstrated safety and efficacy in treating symptoms of schizophrenia in a double-blind, placebo-controlled trial. |
2017-05-25 |
2023-08-13 |
Not clear |
| Shih-Fen Chen, Yu-Chih She. 5-HT1A C-1019G (rs6295) Predicts Aripiprazole Treatment Response Specifically for Cognitive and Depressive Symptoms in Schizophrenia. Journal of clinical psychopharmacology. vol 37. issue 1. 2017-05-10. PMID:28027114. |
5-ht1a c-1019g (rs6295) predicts aripiprazole treatment response specifically for cognitive and depressive symptoms in schizophrenia. |
2017-05-10 |
2023-08-13 |
Not clear |
| Yoshiteru Takekita, Alessandro Serrett. Is long-acting injectable aripiprazole useful for the treatment of acute exacerbation of schizophrenia? Evidence-based mental health. vol 19. issue 4. 2017-05-01. PMID:27586196. |
is long-acting injectable aripiprazole useful for the treatment of acute exacerbation of schizophrenia? |
2017-05-01 |
2023-08-13 |
Not clear |
| Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Kiyokazu Atake, Ryohei Igata, Yuki Konishi, Hiroki Beppu, Hirotaka Tominag. Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia. International journal of molecular sciences. vol 18. issue 3. 2017-04-25. PMID:28272307. |
blood biomarkers predict the cognitive effects of aripiprazole in patients with acute schizophrenia. |
2017-04-25 |
2023-08-13 |
Not clear |
| Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Kiyokazu Atake, Ryohei Igata, Yuki Konishi, Hiroki Beppu, Hirotaka Tominag. Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia. International journal of molecular sciences. vol 18. issue 3. 2017-04-25. PMID:28272307. |
aripiprazole has been reported to exert variable effects on cognitive function in patients with schizophrenia. |
2017-04-25 |
2023-08-13 |
Not clear |
| Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Kiyokazu Atake, Ryohei Igata, Yuki Konishi, Hiroki Beppu, Hirotaka Tominag. Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia. International journal of molecular sciences. vol 18. issue 3. 2017-04-25. PMID:28272307. |
therefore, in the present study, we evaluated biological markers, clinical data, and psychiatric symptoms in order to identify factors that influence cognitive function in patients with schizophrenia undergoing aripiprazole treatment. |
2017-04-25 |
2023-08-13 |
Not clear |
| Wei Zheng, Ying-Jun Zheng, Xian-Bin Li, Yi-Lang Tang, Chuan-Yue Wang, Ying-Qiang Xiang, Jose de Leo. Efficacy and Safety of Adjunctive Aripiprazole in Schizophrenia: Meta-Analysis of Randomized Controlled Trials. Journal of clinical psychopharmacology. vol 36. issue 6. 2017-04-12. PMID:27755219. |
efficacy and safety of adjunctive aripiprazole in schizophrenia: meta-analysis of randomized controlled trials. |
2017-04-12 |
2023-08-13 |
Not clear |
| Wei Zheng, Ying-Jun Zheng, Xian-Bin Li, Yi-Lang Tang, Chuan-Yue Wang, Ying-Qiang Xiang, Jose de Leo. Efficacy and Safety of Adjunctive Aripiprazole in Schizophrenia: Meta-Analysis of Randomized Controlled Trials. Journal of clinical psychopharmacology. vol 36. issue 6. 2017-04-12. PMID:27755219. |
this meta-analysis of randomized controlled trials (rcts) evaluated the efficacy and safety of adding aripiprazole to other antipsychotics in schizophrenia. |
2017-04-12 |
2023-08-13 |
Not clear |
| J Fujioi, K Iwamoto, M Banno, T Kikuchi, B Aleksic, N Ozak. Effect of Adjunctive Aripiprazole on Sexual Dysfunction in Schizophrenia: A Preliminary Open-Label Study. Pharmacopsychiatry. vol 50. issue 2. 2017-03-17. PMID:27656915. |
effect of adjunctive aripiprazole on sexual dysfunction in schizophrenia: a preliminary open-label study. |
2017-03-17 |
2023-08-13 |
Not clear |
| Keiko Naono-Nagatomo, Hisao Naono, Hiroshi Abe, Ryuichiro Takeda, Hideki Funahashi, Daisuke Uchimura, Yasushi Ishid. Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia: A case series. Asian journal of psychiatry. vol 25. 2017-03-13. PMID:28262171. |
partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia: a case series. |
2017-03-13 |
2023-08-13 |
Not clear |
| P Ratajczak, K Kus, K Gołembiowska, K Noworyta-Sokołowska, A Woźniak, T Zaprutko, E Nowakowsk. The influence of aripiprazole and olanzapine on neurotransmitters level in frontal cortex of prenatally stressed rats. Environmental toxicology and pharmacology. vol 46. 2017-02-08. PMID:27458700. |
the study aims to verify whether alterations in the level of neurotransmitters have occurred in prenatally stressed rats (animal model of schizophrenia), and whether aripiprazole (ari) and olanzapine (ola) modify this level. |
2017-02-08 |
2023-08-13 |
rat |
| Gianna Sepede, Giuseppe Di Iorio, Maria Chiara Spano, Marco Lorusso, Fabiola Sarchione, Rita Santacroce, Rosa Maria Salerno, Massimo Di Giannantoni. A Case of Resistant Schizophrenia Successfully Treated With Clozapine/Long-acting Injectable Aripiprazole Combination. Clinical neuropharmacology. vol 39. issue 6. 2017-01-23. PMID:27764052. |
a case of resistant schizophrenia successfully treated with clozapine/long-acting injectable aripiprazole combination. |
2017-01-23 |
2023-08-13 |
Not clear |
| Chein-Heng Lin, Yi-Fen Tsai, Wei-Lieh Huan. Aripiprazole relieves catatonia but worsens hallucination in a patient with catatonic schizophrenia. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists. vol 8. issue 2. 2017-01-02. PMID:27062667. |
aripiprazole relieves catatonia but worsens hallucination in a patient with catatonic schizophrenia. |
2017-01-02 |
2023-08-13 |
Not clear |
| Satoko Yamashita, Tsuyoshi Miyaoka, Michiharu Nagahama, Masa Ieda, Keiko Tsuchie, Rei Wake, Jun Horiguch. Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report. Clinical schizophrenia & related psychoses. vol 10. issue 1. 2016-12-30. PMID:24047761. |
treatment of paroxysmal perceptual alteration in catatonic schizophrenia by switching to aripiprazole from risperidone: a case report. |
2016-12-30 |
2023-08-12 |
Not clear |
| Satoko Yamashita, Tsuyoshi Miyaoka, Michiharu Nagahama, Masa Ieda, Keiko Tsuchie, Rei Wake, Jun Horiguch. Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report. Clinical schizophrenia & related psychoses. vol 10. issue 1. 2016-12-30. PMID:24047761. |
we present a case of ppa in catatonic schizophrenia that was successfully treated by switching to aripiprazole from risperidone. |
2016-12-30 |
2023-08-12 |
Not clear |
| Andrea Fagiolini, Emilia Alfonsi, Giovanni Amodeo, Mario Cenci, Michele Di Lella, Francesco Farinella, Fabrizio Ferraiuolo, David Fraguas, Natale Loparco, Luis Gutierrez-Rojas, Maria Laura Mignone, Giuseppe Pataracchia, Gianluca Pillai, Felicia Russo, Vanessa Sanchez-Gistau, Franco Spinogatti, Marco Toscano, Vincenzo Villari, Sergio De Filippi. Switching long acting antipsychotic medications to aripiprazole long acting once-a-month: expert consensus by a panel of Italian and Spanish psychiatrists. Expert opinion on drug safety. vol 15. issue 4. 2016-12-27. PMID:26886162. |
aripiprazole long acting once-monthly (aom) is a long acting atypical antipsychotic with proven efficacy in schizophrenia and with a pharmacological and a side effect profile that is different from other antipsychotics. |
2016-12-27 |
2023-08-13 |
Not clear |
| Piotr Ratajczak, Krzysztof Kus, Wojciech Giermaziak, Elżbieta Nowakowsk. The influence of aripiprazole and olanzapine on the anxiolytic-like effect observed in prenatally stressed rats (animal model of schizophrenia) exposed to the ethyl alcohol. Pharmacological reports : PR. vol 68. issue 2. 2016-12-13. PMID:26922547. |
the influence of aripiprazole and olanzapine on the anxiolytic-like effect observed in prenatally stressed rats (animal model of schizophrenia) exposed to the ethyl alcohol. |
2016-12-13 |
2023-08-13 |
rat |
| Piotr Ratajczak, Krzysztof Kus, Wojciech Giermaziak, Elżbieta Nowakowsk. The influence of aripiprazole and olanzapine on the anxiolytic-like effect observed in prenatally stressed rats (animal model of schizophrenia) exposed to the ethyl alcohol. Pharmacological reports : PR. vol 68. issue 2. 2016-12-13. PMID:26922547. |
the aim of the study was to find whether anxiety-like behavior is found in prenatally stressed rats (animal model of schizophrenia) and whether aripiprazole (ari, 1.5mg/kg) and olanzapine (ola, 0.5mg/kg) modify those functions. |
2016-12-13 |
2023-08-13 |
rat |